Study: Alexis 2014, Journal of Drugs in Dermatology

A subgroup analysis to evaluate the efficacy and safety of adapalene-benzoyl peroxide topical gel in black subjects with moderate acne

Citation

Alexis AF, Johnson LA, Kerrouche N, Callender VD (2014). Journal of Drugs in Dermatology. PubMed id 24509968.

Open on PubMed

Cards that cite this study (1)

Each card gives its own wording for who was tested, how and what was found.

  • Acne on dark skin Tier B thin

    A Black subjects with moderate acne, pooled from three randomised trials (3,855 people in total) (n=subgroup size not in abstract)

    Post hoc subgroup analysis of three 12-week double-blind placebo-controlled trials of adapalene-benzoyl peroxide gel.

    More Black participants had treatment success with adapalene-benzoyl peroxide than with vehicle at week 12, with lower lesion counts from week 1. It was well tolerated and no treatment-related dark marks were seen.

    As recorded in this card: Alexis AF, Johnson LA, Kerrouche N, Callender VD (2014), Journal of Drugs in Dermatology, [primary]

    Note: Subgroup of industry-type trials; funding not stated in the abstract.

This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.